Octavio O.
- Country
- Spain
- Department
- Anestesiología
Research Overview
Data & Insights
Has run more than one trial at 0 of 9 partner sites.
Specializations
Cardiovascular Atherosclerosis and Event Prevention
Dr. Octavio Orte concentrates on the management of atherosclerotic cardiovascular disease and the reduction of major adverse cardiovascular events through innovative lipid‑lowering strategies.
- Lipid modulation and LDL‑C lowering
- Primary and secondary cardiovascular risk reduction
- Integration of RNA‑based therapeutics
- Long‑term outcome monitoring
His work aligns with emerging approaches that aim to sustain vascular health in high‑risk populations.
Atrial Fibrillation and Stroke Mitigation
In the realm of cardiac arrhythmias, Dr. Orte focuses on atrial fibrillation and the prevention of thrombo‑embolic complications for patients who cannot use conventional anticoagulants.
- Alternative anticoagulation pathways
- Stroke risk assessment and reduction
- Management of patients unsuitable for oral anticoagulants
- Evaluation of novel antithrombotic agents
His investigations seek to broaden therapeutic options for this prevalent rhythm disorder.
Heart Failure with Preserved and Mildly Reduced Ejection Fraction
Dr. Orte’s portfolio includes the study of heart failure with preserved ejection fraction and heart failure with mildly reduced ejection fraction, especially when accompanied by systemic inflammation and obesity.
- Inflammatory modulation in HFpEF/HFmrEF
- Obesity‑related cardiac dysfunction
- Hospitalization and mortality risk reduction
- Combined metabolic‑inflammatory therapeutic strategies
These efforts target the complex phenotype that characterizes contemporary heart‑failure care.
Cardiac Light‑Chain Amyloidosis
Within systemic amyloidosis, Dr. Orte directs attention to AL amyloidosis with cardiac involvement, aiming to improve survival and reduce cardiovascular admissions.
- Plasma cell dyscrasia treatment integration
- Cardiac organ protection
- Overall survival enhancement
- Safety profiling of combination regimens
This focus supports the development of targeted therapies for this high‑mortality condition.
Geographic Atrophy in Age‑Related Macular Degeneration
Dr. Orte also contributes to ocular research, specifically the management of geographic atrophy secondary to age‑related macular degeneration through complement system inhibition.
- Complement component 5 (C5) blockade
- Lesion growth deceleration
- Preservation of visual function
- Long‑term safety of innate‑immune modulation
His work seeks to address an unmet need in progressive retinal disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.